All Stories

  1. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

    Article • Internal and Emergency Medicine, April 2020, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  2. Morbid Obesity and Mortality in Patients With VTE

    Article • CHEST Journal, January 2020, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  3. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Article • Internal and Emergency Medicine, November 2019, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  4. Rischio clinico in sanità e prevenzione dei rischi del paziente ricoverato in ospedale

    Article • Italian Journal of Medicine, July 2019, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  5. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Article • Internal and Emergency Medicine, June 2019, Springer Science + Business Media

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  6. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Article • Internal and Emergency Medicine, May 2019, Springer Science + Business Media

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  7. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

    Article • New England Journal of Medicine, September 2018, New England Journal of Medicine (NEJM/MMS)

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi, Professor Dmitry Zateyshchikov

  8. Ultrasound Elastography is useful to distinguish Acute and Chronic Deep Vein Thrombosis

    Article • Journal of Thrombosis and Haemostasis, September 2018, Wiley

    MD Matteo Giorgi-Pierfranceschi

  9. Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation

    Article • European Journal of Preventive Cardiology, August 2018, SAGE Publications

    MD Matteo Giorgi-Pierfranceschi

  10. Penile self-amputation

    Article • Internal and Emergency Medicine, June 2018, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  11. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

    Article • Thrombosis Research, April 2018, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  12. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism

    Article • Journal of Thrombosis and Thrombolysis, January 2018, Springer Science + Business Media

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  13. What We are Learning from Real World Data on Rivaroxaban for the Treatment of VTE: An Overview

    Article • Journal of Blood & Lymph, January 2018, OMICS Publishing Group

    MD Matteo Giorgi-Pierfranceschi

  14. General Practitioner–Performed Compression Ultrasonography for Diagnosis of Deep Vein Thrombosis of the Leg: A Multicenter, Prospective Cohort Study

    Article • The Annals of Family Medicine, November 2017, Annals of Family Medicine

    MD Matteo Giorgi-Pierfranceschi

  15. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

    Article • Research and Practice in Thrombosis and Haemostasis, September 2017, Wiley

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  16. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

    Article • Clinical Pharmacology & Therapeutics, August 2017, Wiley

    MD Matteo Giorgi-Pierfranceschi

  17. Dabigatran in nonvalvular atrial fibrillation

    Article • Journal of Cardiovascular Medicine, July 2017, Wolters Kluwer Health

    MD Matteo Giorgi-Pierfranceschi

  18. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    Article • The American Journal of Medicine, May 2017, Elsevier

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  19. Saper desistere per curare fino in fondo: come intraprendere il migliore percorso di assistenza nel Paziente con grave insufficienza d’organo in Medicina Interna?

    Article • Italian Journal of Medicine, April 2017, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  20. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

    Article • The American Journal of Medicine, April 2017, Elsevier

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  21. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Article • CHEST Journal, March 2017, Elsevier

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  22. Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism

    Article • Journal of Thrombosis and Haemostasis, February 2017, Wiley

    MD Matteo Giorgi-Pierfranceschi

  23. Is Procalcitonin Really Useful for Diagnosis and Prognosis of COPD Exacerbations Requiring Mechanical Ventilation?

    Article • Respiration, January 2017, Karger Publishers

    MD Matteo Giorgi-Pierfranceschi

  24. Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound

    Article • Blood Coagulation & Fibrinolysis, January 2017, Wolters Kluwer Health

    MD Matteo Giorgi-Pierfranceschi

  25. Predictors of active cancer thromboembolic outcomes

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    MD Matteo Giorgi-Pierfranceschi

  26. Sepsis and septic shock: a practical management according to Sepsis-3 diagnostic criteria

    Article • Italian Journal of Medicine, December 2016, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  27. Sepsis in internal wards: results of an Italian multicenter prospective study

    Article • Italian Journal of Medicine, December 2016, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  28. Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians

    Article • Internal and Emergency Medicine, November 2016, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  29. Comparison of the Accuracy of Nurse-Performed and Physician-Performed Lung Ultrasound in the Diagnosis of Cardiogenic Dyspnea

    Article • CHEST Journal, August 2016, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  30. Acquired Hemophilia Treated Using Low-Dose of Rituximab

    Article • Journal of the American Geriatrics Society, July 2016, Wiley

    Dr Nicola Mumoli, MD Matteo Giorgi-Pierfranceschi

  31. Argatroban for Treatment of Heparin-Induced Thrombocytopenia and Thrombosis in a Patient with Multiple Myeloma Undergoing Hemodialysis

    Article • Journal of the American Geriatrics Society, July 2016, Wiley

    MD Matteo Giorgi-Pierfranceschi

  32. Accuracy of Nurse-Performed Lung Ultrasound in Patients With Acute Dyspnea

    Article • Medicine, March 2016, Wolters Kluwer Health

    MD Matteo Giorgi-Pierfranceschi

  33. Progesterone Levels in Men with Unprovoked Deep Vein Thrombosis

    Article • Journal of the American Geriatrics Society, January 2016, Wiley

    MD Matteo Giorgi-Pierfranceschi

  34. La ventilazione non invasiva in Medicina Interna

    Article • Italian Journal of Medicine, December 2015, PAGEPress Publications

    Professor Enrico M. Clini, MD Matteo Giorgi-Pierfranceschi

  35. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

    Article • Medicine, November 2015, Wolters Kluwer Health

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  36. Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice

    Article • Annals of Medicine, September 2015, Taylor & Francis

    MD Matteo Giorgi-Pierfranceschi

  37. Computed tomography perfusion-based thrombolysis in wake-up stroke

    Article • Internal and Emergency Medicine, September 2015, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  38. The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism

    Article • Blood Coagulation & Fibrinolysis, September 2015, Wolters Kluwer Health

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  39. Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry

    Article • Journal of Thrombosis and Thrombolysis, June 2015, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  40. Endogenous sex hormone levels in men with unprovoked deep-vein thrombosis

    Article • Thrombosis and Haemostasis, January 2015, Schattauer GmbH

    MD Matteo Giorgi-Pierfranceschi

  41. Venous thromboembolism in patients undergoing shoulder surgery: Findings from the RECOS Registry

    Article • Thrombosis Research, August 2014, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  42. Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry

    Article • Internal and Emergency Medicine, May 2014, Springer Science + Business Media

    Dr Raffaele Pesavento, MD Matteo Giorgi-Pierfranceschi

  43. Prescription appropriateness of empiric antibiotic therapy: survey in the internal medicine departments of the Emilia Romagna region

    Article • Italian Journal of Medicine, May 2014, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  44. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

    Article • Thrombosis Research, May 2014, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  45. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs

    Article • Journal of Vascular Surgery, May 2014, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  46. New oral anticoagulants: key messages for clinicians

    Article • Italian Journal of Medicine, December 2013, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  47. Prophylaxis of Venous Thromboembolism with Low Molecular Weight Heparin in Bariatric Surgery: a Prospective, Randomised Pilot Study Evaluating Two Doses of Parnaparin (BAFLUX Study)

    Article • Obesity Surgery, October 2013, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  48. REACH, PATHOS and SIRIO: indications for managing atherothrombosis

    Article • Italian Journal of Medicine, May 2013, PAGEPress Publications

    MD Matteo Giorgi-Pierfranceschi

  49. Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

    Article • New England Journal of Medicine, February 2013, New England Journal of Medicine (NEJM/MMS)

    MD Matteo Giorgi-Pierfranceschi

  50. The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury

    Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

    MD Matteo Giorgi-Pierfranceschi

  51. Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study

    Article • Journal of Thrombosis and Haemostasis, October 2012, Wiley

    MD Matteo Giorgi-Pierfranceschi

  52. C0208 Prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The fondair study

    Article • Thrombosis Research, October 2012, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  53. Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

    Article • Journal of Thrombosis and Haemostasis, July 2012, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  54. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

    Article • New England Journal of Medicine, April 2012, New England Journal of Medicine (NEJM/MMS)

    Dr Jorge Roig , MD Matteo Giorgi-Pierfranceschi

  55. Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

    Article • New England Journal of Medicine, December 2011, New England Journal of Medicine (NEJM/MMS)

    Job Harenberg, MD Matteo Giorgi-Pierfranceschi

  56. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer

    Article • Journal of Thrombosis and Haemostasis, May 2011, Wiley

    MD Matteo Giorgi-Pierfranceschi

  57. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists

    Article • Thrombosis and Haemostasis, January 2011, Thieme Publishing Group

    MD Matteo Giorgi-Pierfranceschi

  58. OC-01 Prognostic relevance of asymptomatic venous thromboembolism in patients with cancer

    Article • Thrombosis Research, April 2010, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  59. PO-76 Effectiveness of recombinant factor VIIa in haemorragic cancer-related disseminated intravascular coagulation: a case report

    Article • Thrombosis Research, April 2010, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  60. Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review

    Article • Internal and Emergency Medicine, August 2009, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi

  61. Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis

    Article • Annals of Internal Medicine, May 2009, American College of Physicians

    MD Matteo Giorgi-Pierfranceschi

  62. Successful Protein C Concentrate Administration during Initiation of Oral Anticoagulation in Adult Patients with Severe Congenital Protein C Deficiency: Report of Two Cases

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2007, Karger Publishers

    MD Matteo Giorgi-Pierfranceschi

  63. Venous Thromboembolism Prevention in Patients with Heart Failure: An Often Neglected Issue

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2007, Karger Publishers

    MD Matteo Giorgi-Pierfranceschi

  64. Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation

    Article • Journal of Thrombosis and Haemostasis, May 2006, Wiley

    MD Matteo Giorgi-Pierfranceschi

  65. Lung water is a critical determinant of functional capacity in congestive heart failure

    Article • Journal of Cardiac Failure, September 1998, Elsevier

    MD Matteo Giorgi-Pierfranceschi

  66. Magnesium in Liver Cirrhosis

    Article • January 1997, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi